The Immune Response Corporation Announces Four Abstracts Accepted at Two Prestigious International Scientific Conferences
New Data on HIV Product Candidate, IR103 to Be Presented
22-Apr-2004 -
Carlsbad, Calif. - The Immune Response Corporation, a biopharmaceutical company developing immune-based therapies for HIV and select other diseases, announced that four abstracts related to its product candidates have been accepted for poster presentations at two prestigious scientific ...
AIDS
diseases
immunology
+3